Article

OneOncology Launches to Enable Better Cancer Care in Communities Across America

Three leading oncology practices unite with partners in technology and finance to announce the launch of OneOncology, a patient-centric, physician-driven, and technology-powered company with a mission to improve the lives of everyone living with cancer.

Three leading oncology practices unite with partners in technology and finance to announce the launch of OneOncology, a patient-centric, physician-driven, and technology-powered company with a mission to improve the lives of everyone living with cancer.

An estimated 38% of Americans will be diagnosed with cancer in their lifetimes. Fortunately, with breakthroughs in diagnostic testing, targeted and immunotherapies, and surgical procedures, cancer is being detected earlier and survivorship is increasing. More than half of those diagnosed with cancer in the US are being treated in a community-based setting, providing high-quality care closer to patients’ homes, at costs up to 60% less than in acute care hospitals.

Despite their critical role, community oncology practices face enormous challenges, including increased pressure from hospital consolidation, limited resources to invest in innovation, and continued shifts to alternative payment models.

OneOncology empowers community oncology practices by supporting the entire continuum of care, including prevention and diagnosis, research and treatment, long-term survivorship, and palliative and hospice care. Through this comprehensive approach, OneOncology aims to achieve improved patient experience and outcomes while benefiting their providers and payers through better aligned payment models.

Read the full release.

Related Videos
Robin Glasco, MBA
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Sandra Cuellar, PharmD
Screenshot of an interview with Nadine Barrett, PhD
Neil Goldfarb, GPBCH
Dr Bonnie Qin
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
dr carol regueiro
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo